File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.bbrc.2004.06.015
- Scopus: eid_2-s2.0-3142528536
- PMID: 15240104
- WOS: WOS:000222723200011
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Rapid preparation of human urine and plasma samples for analysis of F 2-isoprostanes by gas chromatography-mass spectrometry
Title | Rapid preparation of human urine and plasma samples for analysis of F 2-isoprostanes by gas chromatography-mass spectrometry |
---|---|
Authors | |
Keywords | 8-Iso-PGF2α F2-isoprostane GC-MS-NCI iPF 2α Oxidative stress SPE |
Issue Date | 2004 |
Publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/wps/find/journaldescription.cws_home/622790/description |
Citation | Biochemical And Biophysical Research Communications, 2004, v. 320 n. 3, p. 696-702 How to Cite? |
Abstract | Reliable MS-based methods have been developed for the measurement of free and esterified F2-isoprostanes. However, prior to sample analysis several steps of purification, including solid-phase extraction followed by TLC or HPLC, are usually required, making it tedious to analyze large sample numbers, e.g., for population studies. We report a quick sample purification method using anion exchange solid phase extraction (SPE), which is highly selective for acidic compounds. Urine and hydrolyzed plasma of healthy individuals were acidified before SPE extraction, washed with 4 different solvent mixtures and finally eluted with ethyl acetate. The eluted samples were first derivatized with pentafluorobenzyl bromide followed by a second derivatization with bis-(trimethylsilyl)trifluoroacetamide. F 2-isoprostanes were analyzed by GC-MS-NCI. The method was highly sensitive; the limit of detection at 5:1 signal-to-noise ratio was 0.037ng/ml and 0.007ng/mg creatinine for plasma and urine, respectively. Anion exchange SPE extraction for F2-isoprostane showed recovery of 55-65% and high linearity for concentration 0-1.0ng/ml for urine (CV=4.08%, r2=0.990) and 0-0.5ng/ml for plasma (CV=4.07%, r2=0.998). Fasting for 6h significantly increased plasma F2-isoprostanes levels, which has implications for the design of intervention studies using this biomarker. © 2004 Elsevier Inc. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/178925 |
ISSN | 2023 Impact Factor: 2.5 2023 SCImago Journal Rankings: 0.770 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, CYJ | en_US |
dc.contributor.author | Jenner, AM | en_US |
dc.contributor.author | Halliwell, B | en_US |
dc.date.accessioned | 2012-12-19T09:50:46Z | - |
dc.date.available | 2012-12-19T09:50:46Z | - |
dc.date.issued | 2004 | en_US |
dc.identifier.citation | Biochemical And Biophysical Research Communications, 2004, v. 320 n. 3, p. 696-702 | en_US |
dc.identifier.issn | 0006-291X | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/178925 | - |
dc.description.abstract | Reliable MS-based methods have been developed for the measurement of free and esterified F2-isoprostanes. However, prior to sample analysis several steps of purification, including solid-phase extraction followed by TLC or HPLC, are usually required, making it tedious to analyze large sample numbers, e.g., for population studies. We report a quick sample purification method using anion exchange solid phase extraction (SPE), which is highly selective for acidic compounds. Urine and hydrolyzed plasma of healthy individuals were acidified before SPE extraction, washed with 4 different solvent mixtures and finally eluted with ethyl acetate. The eluted samples were first derivatized with pentafluorobenzyl bromide followed by a second derivatization with bis-(trimethylsilyl)trifluoroacetamide. F 2-isoprostanes were analyzed by GC-MS-NCI. The method was highly sensitive; the limit of detection at 5:1 signal-to-noise ratio was 0.037ng/ml and 0.007ng/mg creatinine for plasma and urine, respectively. Anion exchange SPE extraction for F2-isoprostane showed recovery of 55-65% and high linearity for concentration 0-1.0ng/ml for urine (CV=4.08%, r2=0.990) and 0-0.5ng/ml for plasma (CV=4.07%, r2=0.998). Fasting for 6h significantly increased plasma F2-isoprostanes levels, which has implications for the design of intervention studies using this biomarker. © 2004 Elsevier Inc. All rights reserved. | en_US |
dc.language | eng | en_US |
dc.publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/wps/find/journaldescription.cws_home/622790/description | en_US |
dc.relation.ispartof | Biochemical and Biophysical Research Communications | en_US |
dc.subject | 8-Iso-PGF2α | - |
dc.subject | F2-isoprostane | - |
dc.subject | GC-MS-NCI | - |
dc.subject | iPF 2α | - |
dc.subject | Oxidative stress | - |
dc.subject | SPE | - |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Blood Chemical Analysis - Methods | en_US |
dc.subject.mesh | F2-Isoprostanes - Blood - Urine | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Gas Chromatography-Mass Spectrometry - Methods | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Reproducibility Of Results | en_US |
dc.subject.mesh | Sensitivity And Specificity | en_US |
dc.subject.mesh | Specimen Handling - Methods | en_US |
dc.subject.mesh | Urinalysis - Methods | en_US |
dc.title | Rapid preparation of human urine and plasma samples for analysis of F 2-isoprostanes by gas chromatography-mass spectrometry | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lee, CYJ: jettylee@hku.hk | en_US |
dc.identifier.authority | Lee, CYJ=rp01511 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.bbrc.2004.06.015 | en_US |
dc.identifier.pmid | 15240104 | - |
dc.identifier.scopus | eid_2-s2.0-3142528536 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-3142528536&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 320 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.spage | 696 | en_US |
dc.identifier.epage | 702 | en_US |
dc.identifier.isi | WOS:000222723200011 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Lee, CYJ=13104265200 | en_US |
dc.identifier.scopusauthorid | Jenner, AM=7006757910 | en_US |
dc.identifier.scopusauthorid | Halliwell, B=7101878919 | en_US |
dc.identifier.issnl | 0006-291X | - |